Induction_NN
of_IN
cytokine_NN
expression_NN
in_IN
leukocytes_NNS
by_IN
binding_NN
of_IN
thrombin-stimulated_JJ
platelets_NNS
._.

BACKGROUND_NN
:_:
Activated_VBN
platelets_NNS
tether_VBP
and_CC
activate_VBP
myeloid_JJ
leukocytes_NNS
._.

To_TO
investigate_VB
the_DT
potential_JJ
relevance_NN
of_IN
this_DT
mechanism_NN
in_IN
acute_JJ
myocardial_JJ
infarction_NN
-LRB-_-LRB-
AMI_NN
-RRB-_-RRB-
,_,
we_PRP
examined_VBD
cytokine_NN
induction_NN
by_IN
leukocyte-platelet_JJ
adhesion_NN
and_CC
the_DT
occurrence_NN
of_IN
leukocyte-platelet_JJ
conjugates_NNS
in_IN
patients_NNS
with_IN
AMI_NN
._.

METHODS_NNS
AND_CC
RESULTS_NNS
:_:
We_PRP
obtained_VBD
peripheral_JJ
venous_JJ
blood_NN
samples_NNS
in_IN
20_CD
patients_NNS
with_IN
AMI_NN
before_IN
and_CC
daily_RB
for_IN
5_CD
days_NNS
after_IN
direct_JJ
percutaneous_JJ
transluminal_JJ
coronary_JJ
angioplasty_NN
-LRB-_-LRB-
PTCA_NN
-RRB-_-RRB-
and_CC
in_IN
20_CD
patients_NNS
undergoing_VBG
elective_JJ
PTCA_NN
._.

Throughout_IN
the_DT
study_NN
period_NN
,_,
CD41_NN
immunofluorescence_NN
of_IN
leukocytes_NNS
-LRB-_-LRB-
flow_NN
cytometry_NN
-RRB-_-RRB-
revealed_VBD
increased_VBN
leukocyte-platelet_JJ
adhesion_NN
in_IN
patients_NNS
with_IN
AMI_NN
compared_VBN
with_IN
control_JJ
patients_NNS
-LRB-_-LRB-
mean_NN
+_CC
\/_NN
-_:
SE_NNS
of_IN
fluorescence_NN
-LCB-_-LRB-
channels_NNS
-RCB-_-RRB-
before_IN
PTCA_NN
:_:
77_CD
+_CC
\/_NN
-_:
16_CD
versus_CC
35_CD
+_CC
\/_NNP
-_:
9_CD
;_:
P_NN
=_JJ
.003_CD
-RRB-_-RRB-
._.

In_FW
vitro_FW
,_,
thrombin-stimulated_JJ
fixed_JJ
platelets_NNS
bound_VBD
to_TO
neutrophils_NNS
and_CC
monocytes_NNS
._.

Within_IN
2_CD
hours_NNS
,_,
this_DT
resulted_VBD
in_IN
increased_VBN
mRNA_NN
for_IN
interleukin_NN
-LRB-_-LRB-
IL_NN
-RRB-_-RRB-
,_,
1_CD
beta_NN
,_,
IL-8_NN
,_,
and_CC
monocyte_NN
chemoattractant_NN
protein_NN
-LRB-_-LRB-
MCP_NN
-RRB-_-RRB-
-1_CD
in_IN
unfractionated_JJ
leukocytes_NNS
._.

After_IN
4_CD
hours_NNS
,_,
IL-1_NN
beta_NN
and_CC
IL-8_NN
concentration_NN
of_IN
the_DT
cell-free_JJ
supernatant_NN
had_VBD
increased_VBN
by_IN
268_CD
+_CC
\/_CD
-_:
36_CD
%_NN
and_CC
210_CD
+_CC
\/_CD
-_:
7_CD
%_NN
,_,
respectively_RB
,_,
and_CC
cellular_JJ
MCP-1_NN
content_NN
had_VBD
increased_VBN
by_IN
170_NN
+_CC
\/_NN
-_:
8_CD
%_NN
._.

Addition_NN
of_IN
activated_VBN
platelets_NNS
to_TO
adherent_JJ
monocytes_NNS
had_VBD
a_DT
similar_JJ
effect_NN
and_CC
was_VBD
associated_VBN
with_IN
nuclear_JJ
factor-kappa_NN
B_NN
activation_NN
._.

Inhibition_NN
of_IN
binding_NN
by_IN
anti-P_JJ
selectin_NN
antibodies_NNS
reduced_VBD
the_DT
effect_NN
of_IN
activated_VBN
platelets_NNS
on_IN
cytokine_NN
production_NN
._.

CONCLUSIONS_NNS
:_:
In_IN
patients_NNS
with_IN
AMI_NN
,_,
leukocyte-platelet_JJ
adhesion_NN
is_VBZ
increased_VBN
._.

Binding_NN
of_IN
activated_VBN
platelets_NNS
induces_VBZ
IL-1_NN
beta_NN
,_,
IL-8_NN
,_,
and_CC
MCP-1_NN
in_IN
leukocytes_NNS
._.

Our_PRP$
findings_NNS
suggest_VBP
that_IN
leukocyte-platelet_JJ
adhesion_NN
contributes_VBZ
to_TO
the_DT
regulation_NN
of_IN
inflammatory_JJ
responses_NNS
in_IN
AMI_NN
._.

